Publication | Closed Access

Gemcitabine plus Carboplatin Combination Therapy as Second-Line Treatment in Patients with Relapsed Breast Cancer

Second-line TreatmentCarboplatin Combination TherapyBreast OncologyRelapsed Breast CancerMedicinePharmacologyBreast CancerPharmacotherapyCancer TreatmentOncology